Sagent Pharm Inc (SGNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2012 | 06-2012 | 03-2012 | 12-2011 | 09-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 26,789 | 23,286 | 22,281 | 52,203 | 38,206 |
| Marketable Securities | 39,068 | 42,924 | 41,371 | 73,761 | 76,778 |
| Receivables | 30,761 | 24,826 | 24,110 | 29,028 | 31,625 |
| Inventories | 39,356 | 45,829 | 42,198 | 41,487 | 37,789 |
| Other current assets | 1,009 | 2,060 | 1,896 | 2,379 | 340 |
| TOTAL | $140,741 | $142,609 | $135,511 | $200,846 | $187,706 |
| Non-Current Assets | |||||
| PPE Net | 773 | 799 | 837 | 884 | 829 |
| Investments And Advances | 21,754 | 22,369 | 22,354 | 22,762 | 22,727 |
| Intangibles | 4,676 | 5,046 | 5,954 | 5,426 | 4,802 |
| Other Non-Current Assets | 390 | 401 | 319 | 590 | 686 |
| TOTAL | $27,593 | $28,615 | $29,464 | $29,662 | $29,044 |
| Total Assets | $168,334 | $171,224 | $164,975 | $230,508 | $216,750 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 0 | 0 | 8,182 | 8,182 |
| Accounts payable and accrued liabilities | 20,636 | 22,375 | 16,015 | 35,403 | 18,473 |
| Accrued Expenses | 11,268 | 9,384 | 8,090 | 11,387 | 11,516 |
| Other current liabilities | 5,811 | 7,409 | 5,768 | 4,303 | 2,756 |
| TOTAL | $37,715 | $39,168 | $29,873 | $84,142 | $60,596 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 0 | 0 | 4,091 | 6,136 |
| Other Non-Current Liabilities | 6 | 6 | 6 | 606 | 606 |
| TOTAL | $6 | $6 | $6 | $4,697 | $6,742 |
| Total Liabilities | $37,721 | $39,174 | $29,879 | $88,839 | $67,338 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,073 | 27,958 | 27,921 | 27,921 | 27,881 |
| Common Shares | 280 | 280 | 279 | 279 | 279 |
| Retained earnings | -143,589 | -139,839 | -135,123 | -126,834 | -117,709 |
| Other shareholders' equity | 2,923 | 2,546 | 2,500 | 2,162 | 1,703 |
| TOTAL | $130,613 | $132,050 | $135,096 | $141,669 | $149,412 |
| Total Liabilities And Equity | $168,334 | $171,224 | $164,975 | $230,508 | $216,750 |